Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
4.760
+0.160 (3.48%)
At close: May 12, 2025, 4:00 PM
4.950
+0.190 (3.99%)
After-hours: May 12, 2025, 7:27 PM EDT
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $325.40 million as of May 12, 2025. Its market cap has decreased by -42.66% in one year.
Market Cap
325.40M
Enterprise Value
-107.26M
1-Year Change
-42.66%
Ranking
Category
Stock Price
$4.76
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $325.40M, a decrease of -81.87%. That is a compound annual growth rate of -31.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 314.46M | -26.88% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | 1.84B | 2.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |